Soderstrom, Catherine I.
Larsen, Jennifer
Owen, Carolina
Gifondorwa, David
Beidler, David
Yong, Florence H.
Conrad, Patricia
Neubert, Hendrik
Moore, Steven A.
Hassanein, Mohamed
Article History
Received: 17 August 2022
Accepted: 5 December 2022
First Online: 20 December 2022
Declarations
:
: The authors except S.A.M. are employed by Pfizer, Inc., which is involved in the development of gene therapy products. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: The views expressed in this article are those of the authors and do not reflect the official policy of Pfizer.